A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma

[1]  C. Sima,et al.  Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma: A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid Mesothelioma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  M. Tsao,et al.  Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Masafumi Okada,et al.  Nuclear grading of primary pulmonary adenocarcinomas , 2010, Cancer.

[4]  R. Aharonov,et al.  hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. , 2010, Cancer research.

[5]  L. Chirieac,et al.  Prognostic significance of grading in lung adenocarcinoma , 2010, Cancer.

[6]  M. Masuda,et al.  Morphometric Profiling of Lung Cancers—Its Association With Clinicopathologic, Biologic, and Molecular Genetic Features , 2010, The American journal of surgical pathology.

[7]  John M S Bartlett,et al.  Histological grading of invasive breast carcinoma – a simplification of existing methods in a large conservation series with long‐term follow‐up , 2009, Histopathology.

[8]  M. Metintaş,et al.  Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  J. Epstein,et al.  Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia. , 2009 .

[10]  B. Delahunt.  Advances and controversies in grading and staging of renal cell carcinoma , 2009, Modern Pathology.

[11]  C. Moran,et al.  Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. , 2008, American journal of clinical pathology.

[12]  F. Ardissone,et al.  Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  Cindy B. Yeoh,et al.  Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  N. Rioux-Leclercq,et al.  Prognostic ability of simplified nuclear grading of renal cell carcinoma , 2007, Cancer.

[15]  Y. Matsuno,et al.  Cytopathologic factors can predict invasion in small‐sized peripheral lung adenocarcinoma with a bronchioloalveolar carcinoma component , 2006, Cancer.

[16]  E. Brun,et al.  Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. , 2006, Archives of pathology & laboratory medicine.

[17]  H. Pass,et al.  Cellular and molecular parameters of mesothelioma , 2006, Journal of cellular biochemistry.

[18]  A. Olshen,et al.  Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. , 2006, Cancer research.

[19]  William C. Huang,et al.  Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney , 2006, Modern Pathology.

[20]  V. Roggli,et al.  Tumors of the Serosal Membranes , 2006 .

[21]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[22]  Andrew Glass,et al.  Breast carcinoma malignancy grading by Bloom–Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index , 2005, Modern Pathology.

[23]  A. Ochiai,et al.  Cytologic factors associated with prognosis in patients with peripheral adenocarcinoma of the lung measuring 3 cm or less in greatest dimension , 2004, Cancer.

[24]  E. Venkatraman,et al.  A nonparametric test to compare survival distributions with covariate adjustment , 2004 .

[25]  J. Baak,et al.  Prognostic value of proliferation in invasive breast cancer: a review , 2004, Journal of Clinical Pathology.

[26]  C. Cordon-Cardo,et al.  Adrenocortical Adenoma and Carcinoma: Histopathological and Molecular Comparative Analysis , 2003, Modern Pathology.

[27]  J. Epstein,et al.  The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? , 2003, Critical reviews in oncology/hematology.

[28]  M. Vázquez,et al.  Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. , 2003, Chest.

[29]  Bignold Lp.  Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis. , 2003, Histology and histopathology.

[30]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[31]  Qifeng Yang,et al.  Correlation between nuclear grade and biological prognostic variables in invasive Breast Cancer , 2001, Breast cancer.

[32]  S. Hirohashi,et al.  Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. , 2001, Human pathology.

[33]  E. Kay,et al.  Poor agreement in recognition of abnormal mitoses: requirement for standardized and robust definitions , 2001, Histopathology.

[34]  Leslie W Dalton,et al.  Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement , 2000, Modern Pathology.

[35]  Novelli,et al.  MIB‐1 proliferation index correlates with survival in pleural malignant mesothelioma , 2000, Histopathology.

[36]  V. Rusch,et al.  Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.

[37]  W. Travis,et al.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. , 1998, The American journal of surgical pathology.

[38]  S S Cross,et al.  Grading and scoring in histopathology , 1998, Histopathology.

[39]  R. Parwaresch,et al.  Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. , 1998, Human pathology.

[40]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[41]  R. Pethybridge,et al.  Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. , 1998, Human pathology.

[42]  K. Jauhiainen,et al.  Independent clinical, histological and quantitative prognostic factors in transitional‐cell bladder tumours, with special reference to mitotic frequency , 1992, International journal of cancer.

[43]  Y. Collan,et al.  Mitosis counting in tumors. , 1991, Human pathology.

[44]  A. Churg,et al.  The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. , 1982, Archives of pathology & laboratory medicine.

[45]  S. Silverberg,et al.  Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. , 1976, Human pathology.

[46]  J. Russo,et al.  Breast carcinoma malignancy grading by Bloom–Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index , 2005, Modern Pathology.

[47]  L. Bignold.  Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis , 2003 .

[48]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[49]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[50]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.

[51]  G. Giaccone,et al.  Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  F. Collin,et al.  Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.